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One Sentence Summary: Fetal and trophoblast p110α modify resource allocation  30 
 31 
Abstract:  32 
Previous studies suggest that the placental supply of nutrients to the fetus adapts according to fetal 33 
demand. However, the signaling events underlying placental adaptations remain largely unknown. Earlier 34 
work in mice has revealed that loss of the phosphoinositide 3-kinase p110α impairs feto-placental growth 35 
but placental nutrient supply is adaptively increased. Here we explore the role of p110α in the epiblast-36 
derived (fetal) and trophoblast lineages of the conceptus in relation to feto-placental growth and placental 37 
development and transfer function. Using conditional gene manipulations to knock-down p110α either by 38 
~50% or ~100% in the fetal lineages and/or trophoblast, this study shows that p110α in the fetus is 39 
essential for prenatal development and a major regulator of placental phenotype in mice. Complete loss of 40 
fetal p110α caused embryonic death, whilst heterozygous loss resulted in fetal growth restriction and 41 
impaired placental formation and nutrient transport. Loss of trophoblast p110α also resulted in abnormal 42 
placental development, although fetuses were viable. However, in response to complete loss of 43 
trophoblast p110α, the placenta failed to transport sufficient amino acid to match fetal demands for 44 
growth. Using RNA-seq, we identified several genes downstream of p110α in the trophoblast that are 45 
important in adapting placental phenotype to support fetal growth. Further work using CRISPR/Cas9 46 
genome targeting showed that loss of p110α differentially affects the expression of genes in trophoblast 47 
and embryonic stem cells. Our findings thus reveal important, but distinct roles for p110α signaling in the 48 
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different compartments of the conceptus, which control fetal resource acquisition and ultimately affect 49 
healthy growth. 50 
 51 
Introduction 52 
Intrauterine growth is dictated by the genetically-determined fetal drive for growth and the supply of 53 
nutrients and oxygen to the fetus. In turn, fetal substrate supply depends on the functional capacity of the 54 
placenta to transfer nutrients and oxygen from the mother to the fetus. Insufficient fetal substrate supply 55 
prevents the fetus from achieving its genetic growth potential and leads to intrauterine growth restriction, 56 
which affects up to 10% of the population and is associated with perinatal morbidity and mortality 57 
(Baschat et al., 2007; Baschat and Hecher, 2004). Studies have shown that the transport capacity of the 58 
placenta is diminished in human pregnancies associated with fetal growth restriction (Glazier et al., 1997; 59 
Jansson and Powell, 2006), suggesting that placental insufficiency may be the underlying cause of a fetus 60 
failing to achieve its genetic growth potential. However, there is also evidence that placental transport 61 
capacity may adapt to maintain the supply of resources appropriate for the growth potential of the fetus 62 
(Sandovici et al., 2012; Sferruzzi-Perri and Camm, 2016). For instance, the placental capacity to supply 63 
resources to the fetus is higher in the lightest compared to heaviest placentas supporting babies within the 64 
normal birth weight range (Godfrey et al., 1998) and is increased in newborns showing some protection to 65 
the growth-restricting effects of altitude-induced hypoxia (Espinoza et al., 2001; Jackson et al., 1988; 66 
Moore et al., 2001). Studies in mice have also shown that the placenta can adaptively up-regulate its 67 
transport function when the fetal demand for resources exceeds the supply capacity of the placenta, 68 
including following deletion of nutrient transporter or growth-regulatory genes, in naturally small 69 
placentas within litters, and when the maternal provision of substrates is suboptimal (Coan et al., 2008; 70 
Constancia et al., 2005; Dilworth et al., 2010; Higgins et al., 2015; Sferruzzi-Perri et al., 2011; Sferruzzi-71 
Perri et al., 2013b; Vaughan et al., 2013; Wyrwoll et al., 2009). Taken together, these observations 72 
suggest that the placenta may adopt compensatory mechanisms to help meet the fetal genetic drive for 73 
growth, and that perhaps in severe cases of fetal growth restriction such adaptive attempts fail to occur or 74 
are insufficient. However, the signaling events which underlie placental adaptations require elucidation. 75 
 76 
The phosphoinositide 3-kinases (PI3Ks) are a highly conserved family of enzymes, which are thought to 77 
have evolved to regulate growth in relation to nutrient supply (Engelman et al., 2006; Kriplani et al., 78 
2015). In response to receptor activation, they generate lipid second messengers to initiate signaling 79 
cascades, which control important physiological processes as diverse as cellular proliferation, 80 
metabolism, survival, polarity and membrane trafficking (Vanhaesebroeck et al., 2010). They are grouped 81 
into three PI3K classes (I, II and III) on the basis of their substrate preference and sequence similarity and 82 
in mammals, Class I PI3Ks can be further subdivided according to the receptors to which they couple. 83 
Class IA PI3Ks have received the most attention to date and signal downstream of growth factor receptor 84 
tyrosine kinases (Jean and Kiger, 2014). In adult mammalian tissues, the ubiquitously expressed Class IA 85 
isoform, p110 plays a key role in mediating the growth and metabolic effects of insulin and insulin-like 86 
growth factors (IGFs) (Foukas et al., 2006; Knight et al., 2006; Sopasakis et al., 2010), which are major 87 
growth factors that also operate during feto-placental development (Sferruzzi-Perri et al., 2017; Sferruzzi-88 
Perri et al., 2013a). Work in mice has shown that changes in the PI3K pathway, particularly downstream 89 
of p110 were observed in placentas showing adaptive up-regulation of substrate supply to the fetus in 90 
pregnancies challenged by poor maternal environments or genetically-induced placental growth 91 
restriction (Higgins et al., 2015; Sferruzzi-Perri et al., 2011; Sferruzzi-Perri et al., 2013b). These 92 
observations indicate that p110 may be part of a critical signaling cascade that integrates the various 93 
environmental signals involved in adapting placental resource allocation to fetal growth. 94 
 95 
Studies in mice have indicated that embryos die between day 9.5 and 11.5 of pregnancy when they are 96 
homozygous deficient for p110 by either deleting the Pik3ca gene or by a mutation in Pik3ca, rendering 97 
p110 inactive (kinase dead mutation; p110D933A/D933A; /) (Bi et al., 1999; Foukas et al., 2006; 98 
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Graupera et al., 2008). When p110 activity is reduced by half, in mice carrying one copy of the kinase-99 
dead mutation (p110D933A/+; /+), fetuses are viable but weigh 85-90% of wildtype in late gestation 100 
(Foukas et al., 2006; Sferruzzi-Perri et al., 2016). Placental weight is also reduced in association with 101 
defects in the development of the labyrinthine transport region in /+ mutants (Sferruzzi-Perri et al., 102 
2016). However, the capacity of the placenta to transfer maternal glucose and amino acid (via System A) 103 
to the fetus per unit surface area is increased in /+ mutants near term (Sferruzzi-Perri et al., 2016). This 104 
suggests adaptation of placental supply capacity with p110 deficiency. In the /+ mutant the whole 105 
conceptus is heterozygous for the p110 mutation (Sferruzzi-Perri et al., 2016) and the contribution of the 106 
fetal versus the trophoblast cell lineages in driving changes in placental development and adaptive 107 
responses cannot be discerned. This study therefore, sought to answer the following questions: 1) what 108 
effect does fetal versus trophoblast p110 deficiency have on placental phenotype and resource allocation 109 
to fetal growth? 2) does adaptive upregulation of placental transport depend on p110 in the fetal or 110 
trophoblast lineages? and 3) which genes downstream of p110 in the trophoblast compartment of the 111 
conceptus are implicated in adapting placental phenotype to support fetal growth in late mouse 112 
pregnancy? To achieve this, using conditional deletions, we selectively manipulated the expression of the 113 
p110 gene (Pik3ca) in the trophoblast and/or fetal cell lineages and assessed the impact on placental 114 
morphology, transport and transcriptome in relation to fetal growth.  115 
 116 
Results  117 
 118 
Fetal and trophoblast p110 interplay to regulate growth of the conceptus 119 
 120 
We found PI3K p110 was highly expressed by the placental transport labyrinthine zone and the 121 
endocrine junctional zone of the mouse placenta (Fig. S1). We then halved p110 expression in either the 122 
trophoblast or the fetal (epiblast-derived) lineages of the conceptus by mating mice in which exons 18-19 123 
of the Pik3ca gene were flanked by LoxP sites (Graupera et al., 2008), to Cyp19Cre (Wenzel and Leone, 124 
2007) and Meox2Cre (Tallquist and Soriano, 2000) mice, respectively, termed throughout as Het-P and 125 
Het-F. These Cre lines are active in opposite compartments of the conceptus; for Het-P the Cyp19Cre 126 
targets expression in the trophoblast lineages of the placenta but not fetus, labyrinthine fetal capillaries or 127 
mesenchyme in the chorion (Fig. 1A and C). In contrast, in Het-F the Meox2Cre deletes p110 expression 128 
in the fetus and placental labyrinthine fetal capillaries and chorionic mesenchyme but not trophoblast 129 
(Fig. 1B and C) (further information regarding the genetic crosses can be found in Table S1). We then 130 
compared the fetal and placental growth phenotype of the conditional Het-P and Het-F on day 19 of 131 
pregnancy (term ~20 days) to conceptuses with global heterozygous p110 deficiency, achieved with the 132 
ubiquitous CMVCre line (Schwenk et al., 1995) (termed Het-U, Fig. 1C). We found that compared to their 133 
wild-type (WT) littermates, there was no effect of heterozygous deficiency of p110 in the trophoblast on 134 
fetal or placental weight in Het-P mutants (Fig. 2A). However, fetal and placental weights were 10-15% 135 
lighter for Het-F and Het-U conceptuses (Fig. 2B and C). The findings in Het-F and Het-U mutants are 136 
consistent with the proliferation defects observed in embryos with a deficiency in p110 (Bi et al., 1999; 137 
Foukas et al., 2006) and reveal for the first time that p110 in the embryo is important for determining the 138 
size of the placenta.  139 
 140 
Although fetal and not trophoblast p110 deficiency reduced conceptus weight, both affected the 141 
structure of the placenta (Fig. 3A-C). In the labyrinthine region of Het-P conceptuses, the volume of 142 
maternal blood spaces, fetal capillaries and surface area were reduced though trophoblast increased 143 
compared to their WT controls (Fig. 3A). In Het-F conceptuses, the labyrinthine zone, fetal capillaries 144 
and trophoblast volume were decreased versus WT littermates (Fig. 3B). In the ubiquitous p110 145 
heterozygote (Het-U), the volume of the labyrinthine zone, fetal capillaries and trophoblast were reduced, 146 
surface area decreased and barrier to diffusion was greater, relative to WT littermates (Fig. 3C). 147 
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Reassuringly, the same defects in Het-U placental structure were previously observed for /+ mutants 148 
near term (Sferruzzi-Perri et al., 2016). The volume of the endocrine junctional zone in Het-P, Het-F or 149 
Het-U placentas was not significantly altered when compared to the respective WT controls (Fig. S2). 150 
Taken together, these findings indicate that p110α in the fetal and trophoblast lineages of the conceptus 151 
interplay to regulate the development of the transport region in the placenta. 152 
 153 
Fetal and trophoblast p110 both regulate placental resource allocation to fetal growth 154 
To assess whether morphological alterations in the placenta affect placental resource allocation to the 155 
fetus in Het-F, Het-U and Het-P, we measured the uni-directional maternal-fetal transfer of the non-156 
metabolisable analogues of glucose (
3
H-methyl-D glucose; MeG) and a neutral amino acid (
14
C-methyl 157 
amino-isobutyric acid; MeAIB) on day 19 of pregnancy. We assessed fetal counts in relation to the 158 
estimated surface area for transport or to fetal weight, which respectively provided us with indices of the 159 
placental capacity for nutrient transfer and fetal growth relative to supply. We found that in compensation 160 
for the impaired labyrinthine development, Het-P and Het-U placentas transferred more MeG and MeAIB 161 
and Het-F more MeAIB per unit surface area compared to their respective WT littermates (Fig.  4A-C). In 162 
agreement with these findings, mutant fetuses received either normal (MeG in all mutants and MeAIB in 163 
Het-P and Het-F) or increased amount of solutes (MeAIB in Het-U) for their size (Fig. 4D-F). Moreover, 164 
the total fetal accumulation of these solutes was the same in the mutant and WT fetuses (Fig. S3). These 165 
data suggest an adaptive response of both facilitated (MeG) and active (MeAIB) transport functions in 166 
placentas that are morphologically compromised by a lack of fetal or trophoblast p110.  167 
 168 
Fetal p110 is essential for embryonic development and trophoblast p110 is critical for its ability to 169 
up-regulate amino acid transport to match fetal demands for growth  170 
We wanted to know more about the regulation of placental resource allocation to the developing fetus 171 
when there is a loss of fetal and trophoblast p110. In particular, we wondered whether adaptation of 172 
placental transport function would still occur in heterozygous mutants (Het-U) if the trophoblast or fetal 173 
lineages were completely deficient in p110. To do this, we selectively deleted the remaining p110 174 
from the trophoblast or the fetal compartment of Het-U mice, using Cyp19Cre and Meox2Cre, 175 
respectively (termed Hom-P and Hom-F, respectively). We found that deleting the remaining p110 from 176 
the fetal lineages was lethal between days 11 and 12 of pregnancy (Table 1). In contrast to the lethality of 177 
Hom-F embryos, we found viable Hom-P fetuses in late gestation (Fig. 1C and Table S2). The timing of 178 
Hom-F lethality was identical to mutants with constitutive homozygous deficiency of p110 (/; 179 
(Foukas et al., 2006)) and is consistent with the role of p110 in early murine embryonic development 180 
(Xu et al., 2009). Taken together, these findings highlight that p110 in the fetal, but not the trophoblast 181 
compartment of the conceptus, is obligatory for prenatal development. 182 
 183 
When comparing the growth of the Hom-P conceptuses to the control Het-U littermates, we found that 184 
fetal growth was restricted by a further 8% on day 19 of pregnancy (Table 2). However, despite the 185 
reduction in fetal growth, there was no difference in placental weight and labyrinthine morphology in 186 
Hom-P versus Het-U (Table 2). These observations suggest that the more severe reduction in fetal growth 187 
in Hom-P (relative to Het-U), was not caused by additional defects in the formation of the placental 188 
exchange region due to a complete loss of p110 in the trophoblast.  189 
 190 
We wondered whether the greater reduction in fetal growth may have been caused by a defect in placental 191 
transport function (a failure of the placenta to adapt its transfer capacity) in the Hom-P versus the Het-U 192 
mutants. We found that Hom-P placentas transferred 30% less amino acid (MeAIB) for the surface area 193 
available than Het-U littermates (Fig. 5A). Furthermore, Hom-P fetuses received less MeAIB solute for 194 
their size, as well as overall (Fig. 5B and Fig. S4). As the Het-U placenta up-regulated its transport 195 
capacity (Fig. 4C), this suggests that the greater reduction in fetal growth was due to an inability of the 196 
Hom-P placenta to adaptively increase amino acid transfer to the fetus. Placental glucose transfer capacity 197 
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however, was not affected by a lack of placental p110; transfer of MeG by the Hom-P placenta was 198 
equal to Het-U (Fig. 5A-B and Fig. S4). Data on feto-placental growth and placental transfer in Hom-P 199 
compared to wild-type and Het-P, which in contrast, retain p110α in fetus, are shown in Tables S3 and 200 
S4. Collectively, our data suggest that the demand signals of the compromised feto-placental unit for 201 
more amino acids operate via p110 in the trophoblast. 202 
 203 
Several genes downstream of p110 in the trophoblast are implicated in changes in placental 204 
phenotype to support the growing fetus 205 
To identify genes responsible for the phenotypic differences observed between Het-U and Hom-P 206 
placentas at day 19 of pregnancy we compared their transcriptome using RNA-seq. We identified 97 207 
differentially expressed genes, with 61 up- and 36 down-regulated in Hom-P versus Het-U placenta 208 
(Table S5). As expected, the FPKM (fragments per kilobase of transcript per million mapped reads) for 209 
the floxed exons, 18-19 of Pik3ca (Graupera et al., 2008) was diminished for Hom-P versus Het-U (Fig. 210 
S5). Using DAVID functional annotation followed by REViGO filtering we found that genes that were 211 
down-regulated between Het-U and Hom-P placentas have been implicated in cytolysis and cell death, 212 
proteolysis, regulation of immune effector processes, whilst those that were up-regulated have proposed 213 
roles in cellular hormone metabolic processes (Fig. 6A and Fig. S6). We confirmed using qRT-PCR the 214 
differential expression of several granzyme encoding genes, which are implicated in apoptosis (Gzmc, 215 
Gzmf, Gzme, Gzmd, Gzmb and Gzmg) (Table S5). However, paradoxically, we found increased levels of 216 
apoptosis in the junctional zone of the Hom-P relative to the Het-U placenta (Fig. 6B and C). Inspecting 217 
the list of genes from the RNA-seq dataset revealed that expression of the main glucose and System A 218 
amino acid transporters (Slc2a, Slc38a) and their proposed regulators (Mtor, Tbc1d4) (Miinea et al., 2005; 219 
Rosario et al., 2012) was not different between Hom-P and Het-U placentas. However, genes involved in 220 
water and oxygen transport (eg. Aqp1, Aqp5, Hba-a2) were altered (Table S5), suggesting that other 221 
transport capabilities of the placenta may be altered and contribute to the greater fetal growth restriction 222 
observed in the Hom-P versus Het-U. Other differentially expressed genes that were not featured in the 223 
pathway analysis have been implicated in regulating placental physiology (eg, Cdx2, Cited2, Prl5a1, 224 
Prl7c1, Psg19 and Psg22) and pregnancy outcome (eg, Fgl2, Acta2, Ngf and Nov/Ccn3) (Table S5).  225 
 226 
We next identified significant enrichment of binding sites for four transcription factors (STAT1, ARNT2, 227 
HMGA1 and MITF) at the promoters of genes differentially expressed between Hom-P and Het-U 228 
placenta (Figure 6D and E). The mRNA expression of the transcription factors were not altered in the 229 
Hom-P versus Het-U placenta (Table S5), although previous work has shown that their activity is 230 
modified by PI3K signalling (Mounayar et al., 2015; Sheu et al., 2017; Terragni et al., 2011; Zhang et al., 231 
2018) and/or implicated in the development of pregnancy complications related to placental dysfunction 232 
(Than et al., 2018). Therefore, p110 operates via several genes in the trophoblast to alter placental 233 
phenotype to support fetal growth.  234 
 235 
PI3K p110α loss differentially affects the expression of genes in the trophoblast and fetal cell lineages 236 
We wanted to know whether the genes differentially expressed (DEGs) between Hom-P and Het-U 237 
placentas, were expressed in the trophoblast or embryonic lineage of the conceptus. Thus, we aligned our 238 
RNA-seq dataset with existing trophoblast and embryonic stem cell (TS and ES cell) transcriptomes using 239 
SeqMonk (Chrysanthou et al., 2018; Latos et al., 2015). We found that 46 of DEGs were expressed in 240 
both cell types, and of these, 26 were highly enriched in the TS compared to the ES cells (Fig. S7). 241 
Functional analysis revealed that the DEGs enriched in TS cells have been implicated in the control of 242 
extracellular exosome, whereas those enriched in ES cells are involved in regulating gene expression and 243 
extracellular space (Table S6).  These data suggested that p110 may modulate different types of genes in 244 
the trophoblast and fetal cell lineages of the conceptus and that some, but not all of the gene changes 245 
identified in our Hom-P versus Het-U analysis may be a direct consequence of p110 loss in the 246 
trophoblast. To explore these notions further, we deleted exons 18-19 of the Pik3ca gene using 247 
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CRISPR/Cas9, to diminish p110 protein expression in TS cells (Fig. 7A-C). We then quantified the 248 
expression of a subset of DEGs identified in vivo in the mutant p110 and wild-type TS cells (Fig. 7D). 249 
These experiments were additionally performed in ES cells to assess if loss of p110 would have a 250 
similar effect on gene expression, as observed in mutant TS cells.  251 
 252 
Loss of p110 significantly reduced the expression of B2m in mutant TS cells (Fig. 7D), similar to 253 
findings in vivo from the Hom-P versus Het-U placenta (Table S5). We also observed a trend for reduced 254 
expression of Mzp12 upon TS p110 loss, although this did not reach statistical significance with the 255 
small number of biological replicates used (P=0.079; Fig. 7D). However, none of the other DEGs 256 
analyzed were affected by TS p110 deficiency. These data suggest that the mis-regulated pattern of 257 
genes identified in the Hom-P versus Het-U placenta represent a combination of both direct and 258 
secondary effects of trophoblast p110 loss.  259 
 260 
Loss of p110 also had a more prominent impact on the expression of DEGs in ES cells. For instance, 261 
p110 deficiency significantly increased the expression of Cited2, Pdlim3, Creb3l1, Mgst1, Aldh1a3 in 262 
the ES cells (Fig. 7D). For wildtype clones, the expression of the Pik3ca was overall, more uniform in ES 263 
than TS cells (Fig. 7B). Moreover, loss of p110 tended to increase the expression of genes analyzed in 264 
ES cells, but decreased them in TS cells. Taken together, these data demonstrate that pathways 265 
downstream of p110α differentially affect the expression of genes in the trophoblast and fetal cell lineages 266 
of the conceptus.  267 
 268 
Discussion  269 
Here, using in vivo conditional genetic manipulations of p110 we have identified how the trophoblast 270 
and fetal cell lineages interact to control placental resource supply and thereby, affect healthy growth of 271 
the fetus. The major cause of intrauterine growth restriction is placental insufficiency in the developed 272 
world (Baschat and Hecher, 2004). Our results are therefore, important for understanding the etiology of 273 
placental insufficiency and intrauterine growth restriction.    274 
 275 
The data presented here indicate that p110 in the fetal, but not the trophoblast compartment of the 276 
conceptus determines placental size in late mouse pregnancy. The mechanism by which loss of fetal 277 
p110 reduces formation of the placenta is unknown. Elongation of the fetal capillary network is required 278 
for growth of the placenta, particularly its labyrinthine zone (Adamson et al., 2002; Coan et al., 2004). 279 
Reduced fetal capillary formation in the labyrinthine zone of the Het-F could therefore underlie the 280 
reduced placental weight and labyrinthine zone observed and data are consistent with previous work 281 
showing defective angiogenesis and vascular development in the fetus and placenta in response to p110 282 
loss (Graupera et al., 2008; Sferruzzi-Perri et al., 2016). The reduction in fetal and placental weight was 283 
similar for Het-F conceptuses (both reduced by ~11%), suggesting that perhaps the placenta grew to 284 
match the genetically-determined growth requirements of the fetus (Sandovici et al., 2012).  However, it 285 
is also plausible that placental growth decreased to match the experimentally induced slower growth of 286 
the Het-F fetuses. Herein, the direct effects of fetal p110α cannot be isolated from the indirect effects on 287 
the fetal growth restriction in Het-F on day 19 of pregnancy. Thus, future work should assess the 288 
ontogeny of changes in placental phenotype with respect to the growth of the fetus in the Het-F during 289 
gestation. 290 
 291 
The lack of an effect of trophoblast p110 deficiency in Het-P and Hom-P on placental weight was 292 
surprising as both loss of IGF2 and protein kinase B (AKT), which are main up- and down-stream 293 
mediators of PI3K signaling respectively cause placental growth restriction (Constancia et al., 2002; Kent 294 
et al., 2012; Plaks et al., 2011; Yang et al., 2003). Moreover, studies using non-isoform specific inhibitors 295 
have shown that Class 1A PI3Ks mediate the proliferative and survival effects of ligands on trophoblast 296 
in vitro (Diaz et al., 2007; Forbes et al., 2008).  Deleting p110 using the conditional Pik3ca line in the 297 
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current study does not alter the stoichiometry of PI3K complexes (Graupera et al., 2008), and thus it is 298 
unlikely that other PI3K isoforms compensate for the loss of p110 in the trophoblast. In the current 299 
study however, the expression of cell death genes were down-regulated and the level of apoptosis in the 300 
Hom-P compared to Het-U placenta paradoxically upregulated on day 19 of pregnancy (~1 day prior to 301 
term). Differences between gene expression and tissue levels of apoptosis in our study may be relate to 302 
the low volume density (~20%) of the junctional zone in the whole placenta which was used in the 303 
RNAseq analysis.  Assessing the ontogeny of changes in cell death genes and the activation of apoptosis 304 
in the Hom-P placenta is required. Moreover, whether placental weight (as well as morphology) may be 305 
decreased in Hom-P versus Het-U in the last 24h prior to delivery remains to be determined. 306 
 307 
Our stereological analyses of the Het-F, Het-P and Het-U placentas demonstrated that epiblast-derived 308 
and trophoblast p110α have non-overlapping contributions in regulating the development of the placental 309 
exchange region. In particular, p110 in the epiblast-derived compartment determined the size of the 310 
placental labyrinthine zone and its trophoblast constituent, whereas p110 in the trophoblast was 311 
important for expanding the surface area for maternal-fetal exchange. Moreover, p110 in both the 312 
trophoblast and epiblast-derived lineages contributed to the formation of the capillary network and the 313 
thinness of the diffusion barrier in the placental exchange region. These findings are consistent with 314 
previous work demonstrating that the PI3K pathway regulates trophoblast differentiation (Kent et al., 315 
2010) and defects in p110 signaling impair developmental angiogenesis and placental exchange region 316 
morphogenesis (Graupera et al., 2008; Lelievre et al., 2005; Sferruzzi-Perri et al., 2016). As fetal capillary 317 
volume was affected by a deficiency of p110 signaling in the trophoblast, and trophoblast volume was 318 
altered by a deficiency in fetal p110, our data suggest that there is a paracrine communication between 319 
cellular compartments in the placental labyrinthine zone, which occurs via p110 signaling. Paracrine 320 
signaling via p110 may also explain why when comparing the three heterozygote lines, the Het-P 321 
placenta uniquely showed less maternal blood spaces and a greater trophoblast volume. Paracrine 322 
communication between trophoblast and endothelial cell lineages in the labyrinthine zone has been 323 
reported previously for other signaling proteins (Limbourg et al., 2005; Lu et al., 2013; Moreau et al., 324 
2014; Tang et al., 2006). Future work should evaluate the density of different trophoblast cell types in the 325 
labyrinthine zone (eg. syncytial trophoblast layer 1, syncytial trophoblast layer 2 and sinusoidal giant 326 
cells) in the Het-P and other p110α mutant placentas. 327 
 328 
Our analysis of placental transfer function in vivo revealed that independent of specific changes in 329 
placental labyrinthine morphology with fetal versus trophoblast p110 loss, fetal glucose and System A-330 
mediated amino acid supply relative to the size of the fetus, was maintained or even increased due to an 331 
adapting placenta which increased materno-fetal substrate clearance per unit surface area. We found that 332 
in conceptuses with p110 deficiency, this adaptive up-regulation of placental amino acid transport 333 
depended on the expression of p110 in the trophoblast; System A-mediated amino acid transport was 334 
significantly lower for the Hom-P compared to the adapted Het-U placenta. This inability of the Hom-P 335 
placenta to up-regulate System A amino acid transport, may explain, at least partly, the further reduction 336 
in fetal weight, when compared to Het-U. Indeed, inhibiting System A-mediated amino acid transport 337 
during rat pregnancy in vivo leads to fetal growth restriction (Cramer et al., 2002) and reductions in 338 
System A transporter activity occur prior to the onset of intrauterine growth restriction in rats and 339 
baboons (Jansson et al., 2006; Pantham et al., 2016). Previous work has shown that constitutive 340 
heterozygous loss of p110 activity in the conceptus (/+ mutants) does not affect the expression of 341 
glucose (Slc2a) or the sodium coupled System A amino acid transporter (Slc38a) genes in the placenta 342 
(Sferruzzi-Perri et al., 2016). We also did not find differential expression of these transporters in Hom-P 343 
compared to Het-U placenta by RNA-seq. In other cell types, p110 alters the activity of glucose and 344 
sodium transporters on the plasma membrane (Frevert and Kahn, 1997; Katagiri et al., 1996; Wang et al., 345 
2008). Loss of p110 may therefore, alter glucose and amino acid transport to the fetus by the placenta 346 
via post-transcriptional mechanisms. Previous work has shown that when placental supply and fetal 347 
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demand for resources to grow are mis-matched, IGF2 in the fetus may directly or indirectly signal 348 
demand to the placenta to adaptively up-regulate its transport of glucose and amino acids (12, 14, 26, 57). 349 
Our data therefore imply that demand signals of the compromised feto-placental unit, such as IGF2, 350 
operate via p110 in the trophoblast to adapt amino acid supply to the fetus for growth. However, it is 351 
equally possible that fetal demand signals operate via pathway/s independent of p110. Moreover, it is 352 
plausible that these pathway/s may be sufficient to compensate for the effects of moderately down-353 
regulated p110 in the Het-P, but are insufficient when p110 is markedly knocked-down as in the Hom-354 
P. Further work is required to identify the elusive fetal demand/s signals and explore the contribution of 355 
other signaling pathways implicated in environmental sensing, in driving alterations in placental transport 356 
phenotype in response to p110 deficiency, including the mechanistic target of rapamycin (mTOR), 357 
mitogen-activated pathway (MAPK), general control nonrepressed 2 (GCN2), glucokinase, G-protein 358 
coupled-receptors (GPCRs) and adenosine monophosphate-activated protein kinase (AMPK) (Efeyan et 359 
al., 2015). 360 
 361 
Our transcriptomic comparison of the Hom-P and Het-U placentas identified several genes downstream of 362 
p110 that may be important in adapting placental phenotype to support fetal growth. Of note, we found 363 
6 granzyme encoding genes, to be down-regulated in expression between Hom-P and Het-P. Others have 364 
shown that the PI3K pathway regulates granzyme expression and function of different leukocyte 365 
populations (Blanco et al., 2015; Efimova and Kelley, 2009; Jiang et al., 2000), and thus p110α could be 366 
playing a similar role in trophoblast. We also found that some of the genes differentially expressed 367 
between Hom-P and Het-U placenta have been previously implicated in the regulation of trophoblast 368 
differentiation (eg, Cdx2) (Strumpf et al., 2005), growth and transport (Cited2)(Withington et al., 2006) 369 
and hormonal regulation of maternal physiology (Prl5a1, Prl7c1, Psg19 and Psg22) (Moore and 370 
Dveksler, 2014; Soares et al., 2007). Moreover, a number of genes identified have been implicated in 371 
miscarriage (Fgl2) (Clark et al., 2001) and in the development of placental dysfunction in the pregnancy 372 
complication, preeclampsia (Acta2, Ngf and Nov/Ccn3)(Gellhaus et al., 2006; Sahay et al., 2015; Todros 373 
et al., 2007). We found significant enrichment of binding motifs for the transcription factors, STAT1, 374 
ARNT2, HMGA1 and MITF in the promoters of genes differentially expressed between Hom-P and Het-375 
U. Others have demonstrated that the PI3K pathway modulates the activity of three of these transcription 376 
factors (Mounayar et al., 2015; Sheu et al., 2017; Terragni et al., 2011; Zhang et al., 2018) and of note, 377 
there is an interaction between p110α and STAT1 activity (Mounayar et al., 2015). Many of the 378 
differentially expressed genes in Hom-P versus Het-U placenta, were found to be enriched in TS cells 379 
however of the fourteen candidates studied, only one was significantly altered in response to TS cell 380 
p110α deficiency. Thus, the mis-regulated pattern of genes identified in the Hom-P versus Het-U placenta 381 
may be both a direct consequence of p110α in the trophoblast, as well as the result of indirect effects on 382 
the embryonic lineages (such as fetal capillaries) in the placenta, or in the decidua. Single-cell RNA-seq 383 
should be performed on p110 mutant placentas in the future to substantiate this interpretation. Further 384 
work is additionally required to assess more directly the contribution of genes differentially expressed 385 
between Hom-P and Het-U placentas, in adaptive responses of the placenta (Sferruzzi-Perri et al., 2011).  386 
 387 
Loss of p110α in ES cells also affected the expression the candidate genes studied. However, there were 388 
many more candidate genes significantly altered in the mutant ES cells and the pattern of change was 389 
largely distinct to that observed the mutant TS cells. Indeed, genes were typically upregulated in ES cells, 390 
but reduced in TS cells in response to p110 deficiency. Moreover, the genes differentially expressed 391 
between Hom-P and Het-U and enriched in TS and ES cells were predicted to participate in diverse cell 392 
functions, for example extracellular exosome and gene expression, respectively. These data imply that 393 
p110α regulates the expression of different genes and functional pathways in the trophoblast and epiblast-394 
derived tissues of the conceptus. They also reinforce that the embryonic lineages of the conceptus are 395 
more sensitive to p110α loss than the trophoblast, and may provide some explanation for the lethality 396 
observed for the Hom-F but not Hom-P mutants. These findings could be furthered in the future by 397 
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performing RNAseq on TS and ES cells to obtain a complete transcriptomic comparison in response to 398 
p110 deficiency.  399 
 400 
 401 
Previous work has shown that the genotype and environment of the mother modulates placental growth 402 
and transport function (Angiolini et al., 2011; Constancia et al., 2005; Sferruzzi-Perri et al., 2016; 403 
Sferruzzi-Perri et al., 2017; Sferruzzi-Perri et al., 2011). In the current study, all data were obtained from 404 
litters of mixed genotype and only comparisons to their respective control siblings were made to 405 
minimize possible effects of the maternal metabolic environment on placental phenotype. However, 406 
changes in placental phenotype with fetal and trophoblast Pik3ca deletion can still occur within the 407 
homogenous maternal metabolic environment and according to fetal genotype, which was not assessed in 408 
the current study. Future work should therefore, attempt to explore the interaction between maternal 409 
p110 metabolic profile and fetal genotype in the regulation of placental resource allocation. This can be 410 
done initially by measuring maternal hormones and glucose/amino-acid levels in the diverse 411 
fetal/maternal genotype combinations, but quantification of the ‘individual' effects will be highly 412 
challenging. 413 
 414 
Collectively, our data indicate that p110α plays distinct roles in the different compartments of the 415 
conceptus, which ultimately affect placental phenotype and fetal growth. In particular, p110 in the fetal 416 
lineages of the conceptus is essential for prenatal development and a major regulator of placental 417 
phenotype (Fig. 8). Moreover, trophoblast p110 signaling is critical for its ability to up-regulate amino 418 
acid transport to match fetal demands for growth near term. However, the Hom-F and Hom-P have a 419 
heterozygous deficiency of p110α in the trophoblast and epiblast-derived lineages, respectively. Thus, 420 
there may be interactions between the different compartments of the conceptus that are heterozygous and 421 
homozygous deficient in p110α, which may have contributed to the placental and fetal phenotypes 422 
observed for Hom-F and Hom-P. Furthermore, gene disruption may occur up to 1.5 days earlier using the 423 
Meox2Cre, compared to the Cyp19Cre (at around days 5 and 6.5, respectively) (Tallquist and Soriano, 424 
2000; Wenzel and Leone, 2007). Moreover, the Cyp19Cre exhibits mosaic activity (observed herein and 425 
reported previously (Wenzel and Leone, 2007)). Therefore, temporal differences in the timing of Cre 426 
activation and levels of Cre activity between the Meox2Cre and Cyp19Cre lines may have contributed to 427 
feto-placental phenotypes observed for the fetal versus trophoblast p110α mutants, in the current study. In 428 
addition, previous characterization of Meox2Cre line has shown Cre is active in the yolk sac mesoderm 429 
(Tallquist and Soriano, 2000). As the yolk sac is essential for fetal growth, loss of p110α from the yolk 430 
sac mesoderm could have contributed to the fetal phenotypes observed with the Het-F and Hom-F. 431 
Employing alternative strategies to target expression of p110α in different conceptus lineages, such as 432 
using lentiviral-mediated shRNA/siRNA transfection of mouse blastocysts (Georgiades et al., 2007; 433 
Okada et al., 2007) are therefore, warranted in the future. Nevertheless our findings are important in the 434 
context of human pregnancy, as dysregulated expression of both up and down-stream components of the 435 
PI3K pathway in the placenta are associated with abnormal fetal growth and poor pregnancy outcome 436 
(reviewed in (Sferruzzi-Perri et al., 2017)). 437 
 438 
Materials and Methods 439 
 440 
Mice and genotyping 441 
Mice were housed under dark:light 12:12 conditions with free access to water and chow in the University 442 
of Cambridge Animal Facility abiding by the UK Home Office Animals (Scientific Procedures) Act 1986 443 
and local ethics committee. Mice in which exons 18 and 19 of the p110 gene were flanked by LoxP sites 444 
(Pik3ca
Fl
) on a C57Bl6 background were kindly provided by Dr Bart Vanhaesebroeck (University 445 
College London) and Dr Klaus Okkenhaug (Babraham Institute) (Graupera et al., 2008). These were 446 
time-mated with those expressing the Cre recombinase gene under the control of the trophoblast-specific 447 
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human Cyp19 promoter (Wenzel and Leone, 2007), the embryonic Meox2 promoter (Tallquist and 448 
Soriano, 2000) or the ubiquitous CMV promoter (Schwenk et al., 1995). This achieved three models that 449 
had a ~50% decrease in p110α in the trophoblast, fetal lineages or whole conceptus, termed Het-P, Het-F 450 
and Het-U, respectively. Further crosses were performed on a second generation of Het-U mice to 451 
selectively delete the remaining p110 allele in the trophoblast using Cyp19Cre (Hom-P) or fetal lineage 452 
using Meox2Cre (Hom-F). See Table S1 for experimental crosses used. Note the wild-types for the Het-P 453 
and Het-U are the same animals and the Het-U were the controls for Hom-P. The genotypes of the 454 
fetuses/mice were determined by PCR using primers to detect Cyp19Cre (Fwd: 455 
GACCTTGCTGAGATTAGATC and Rev: AGAGAGAAGCATGTTTAGCTGG), Meox2Cre (Fwd: 456 
GGACCACCTTCTTTTGGCTTC, Rev: AAGATGTGGAGAGTACGGGGTAG, Cre: 457 
CAGATCCTCCTCAGAAATCAGC) and CMVCre (Cre Fwd: CGAGTGATGAGGTTCGCAAG, Cre 458 
Rev: TGAGTGAACGAACCTGGTCG, Internal control Fwd: ATGTCTCCAATCCTTGAACACTG and 459 
Internal control Rev: GCAGTGGGAGAAATCAGAACC). This was done using the following cycle 460 
conditions: 94ºC, 3 min, then 35 cycles of 94ºC for 30s, 57ºC for 30s and 72ºC for 90s, and then 72ºC for 461 
7min. Genotyping was also performed by PCR using primers for Pik3ca
Fl
 462 
(Fwd:CTAAGCCCTTAAAGCCTTAC, Rev:CAGCTCCCATCTCAGTTCA and Deletion: 463 
ACACACTGCATCAATGGC) as described previously (Graupera et al., 2008) and by real time PCR 464 
(qRT-PCR) using Taqman probes (Pik3ca: Mm00435672_g1 and Gapdh: Mm99999915_g1) to confirm 465 
deletion in whole fetal and placental tissue homogenates. Due to the mosaic activity of the Cyp19Cre 466 
(Wenzel and Leone, 2007) a cut-off for Pik3ca deletion in the placenta using qRT-PCR was set for <65% 467 
Het-P and <30% for Hom-P.  468 
 469 
To visualize the Cre recombinase activity, Cyp19Cre and Meox2Cre mice were mated to the 470 
Rosa26TdRFP reporter mouse line (Gt(ROSA)26Sor; purchased from the Jackson lab and a generous gift 471 
from Prof William Colledge, University of Cambridge) (Soriano, 1999). Fetuses and placentas were 472 
collected on day 16 of pregnancy, fixed in 4% (wt/vol) PFA, 30% (wt/vol) sucrose and then frozen in 473 
OCT (optimal cutting temperature media, TissueTek) for cryosectioning and staining in DAPI. 474 
 475 
Placental nutrient transfer assays 476 
The unidirectional materno-fetal clearance of the non-metabolisable radioactive tracers, 
14
C-methyl 477 
amino-isobutyric acid (MeAIB) and 
3
H-methyl D-Glucose (MeG) were measured under anaesthesia with 478 
fentanyl-fluanisone (hypnorm):midazolam (hypnovel) in sterile water (1:1:2, Jansen Animal Health) 479 
(Sibley et al., 2004). A 200μl bolus containing 3.5 µCi, of MeAIB (NEN NEC-671; specific activity 480 
1.86GBq/mmol, Perkin Elmer, USA) and 3.5 µCi MeG (NEN NEC-377; specific activity 2.1GBq/mmol) 481 
in physiological saline (0.9% wt/vol) was injected into the maternal jugular vein. Two minutes after tracer 482 
injection, the dam was killed by cervical dislocation, uteri were collected and fetal and placental weights 483 
recorded. Entire litters of placentas were collected for morphological analyses or snap frozen in liquid 484 
nitrogen for quantification of gene expression. Fetuses were decapitated, entire fetal tails taken for DNA 485 
genotyping and then fetuses minced and lysed at 55C in Biosol (National Diagnostics, Atlanta, USA). 486 
Fetal lysates were measured for beta emissions by liquid scintillation counting (Optiphase Hisafe II and 487 
Packard Tri-Carb, 1900; Perkin-Elmer USA) and radioactivity (DPM) in the fetuses was used to calculate 488 
transfer relative to the estimated placental surface area or to fetal weight.  489 
 490 
Placental morphological analyses 491 
Placentas were bisected and one half was fixed in 4% (wt/vol) paraformaldehyde, paraffin-embedding, 492 
exhaustively sectioned at 7 μm and stained with hematoxylin and eosin to analyse gross placental 493 
structure. The other half was fixed in 4% (wt/vol) glutaraldehyde, embedded in Spurr’s epoxy resin and a 494 
single, and 1-μm midline section was cut and then stained with toluidine blue for detailed analysis of 495 
labyrinthine zone (Lz) structure using the Computer Assisted Stereological Toolbox (CAST v2.0) 496 
program as previously described (Coan et al., 2004). Briefly, to determine the volume densities of each Lz 497 
component (fetal capillaries [FC], maternal blood spaces [MBS], trophoblast), point counting was used 498 
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and their densities were multiplied by the estimated volume of the Lz to obtain estimated component 499 
volumes. Surface densities of maternal-facing and fetal-facing interhaemal membrane surfaces were then 500 
determined by counting the number of intersection points along cycloid arcs in random fields of view. 501 
These were converted to absolute surface areas and the total surface area for exchange calculated 502 
(averaged surface area of MBS and FC). The mean interhaemal membrane thickness was determined by 503 
measuring the shortest distance between FC and the closest MBS at random starting locations within the 504 
Lz. Per Lz, 200 measurements were made. The harmonic mean thickness (barrier thickness) was 505 
calculated from the reciprocal of the mean of the reciprocal distances.  506 
 507 
Placental in situ cell death staining 508 
Cells undergoing cell death were detected in paraffin-embedded sections of placenta using the In Situ Cell 509 
Death Detection Kit, TMR red (Sigma Aldrich), according to the manufacturer’s instructions.  The 510 
proportion of TMR red to DAPI stained cells was determined in each placental section using Image J 511 
(freeware software).  512 
 513 
Placental immuno-localisation of p110α expression 514 
 515 
Placental sections were washed with PBS to remove OCT and underwent antigen retrieval with citrate 516 
buffer before immunolabelling for p110α (1:75 dilution, Cell Signaling, C73F8). Sections were treated 517 
with 0.5% Triton X-100 before immunolabelling. Bound antibody was detected using biotinylated goat 518 
anti-rabbit IgG (Abcam, ab6720) followed by streptavidin-conjugated horseradish peroxidase (Rockland, 519 
S000-03) and Sigma fast DAB tablets according to manufacturer instructions. Sections were lightly 520 
counterstained with hematoxylin and mounted in DPX. Negative controls were performed by omission of 521 
the primary antibody. 522 
 523 
Placental RNA sequencing (RNA-seq)  524 
Total RNA was extracted from whole placental halves using the RNeasy Plus Mini Kit (Qiagen, UK) 525 
according to manufacturer’s instructions. RNA-seq libraries were prepared using TruSeq (Illumina) and 526 
the barcoded libraries were combined and submitted for sequencing (50bp single ended on a HiSeq2500) 527 
by the Wellcome Trust-MRC Institute of Metabolic Science Genomics Core Facility. The number of 528 
reads per library was between 14.3 and 33.4 million. Fastq files were aligned to mouse genome GRCm38 529 
with TopHat (version 2.0.11; Kim 2013) and default settings (The mapping percentage varied between 530 
96.2 and 98.3%). Differential expression was performed using Cuffdiff (version 2.1.1; Trapnell 2012) 531 
with the following settings; require a minimum of 5 alignments to conduct significance testing, perform 532 
bias correction, do initial estimation to weight multi-hits. Genes identified as differentially expressed 533 
(DEG) with Cuffdiff significance indicated as q value<0.05 and 1.5-fold expression change. Pathway 534 
analysis was then determined using DAVID gene ontology (Huang da et al., 2009) and redundant GO 535 
terms were filtered-out using REViGO (Supek et al., 2011). 536 
 537 
To search for enrichment of transcription factor binding sites at the promoters of DEG, we used 538 
Eukaryotic Promoter Database (EPD – https://epd.vital-it.ch/index.php) to retrieve the DNA sequences 539 
from 1,000bp upstream to 100bp downstream of the transcriptional start site. These sequences were then 540 
analysed using Analysis of Motif Enrichment (AME v4.12.0 – http://meme-suite.org/tools/ame) by 541 
selecting Mus musculus and HOCOMOCO Mouse (v11 FULL) as motif database. Transcription factors 542 
predicted by AME and Ingenuity Pathway Analysis (IPA) were then used for network visualization, 543 
performed using IPA. 544 
 545 
CRISPR/Cas9 knockout in Trophoblast and Embryonic Stem Cells 546 
For CRISPR/Cas9-mediated deletion of Pik3ca, E14tg2a embryonic stem cells and TS-Rs26 trophoblast 547 
stem cells  (a gift of the Rossant lab, Toronto, Canada) were transfected with Cas9.2A-eGFP plasmid 548 
(Plasmid 48138 Addgene) harbouring guide RNAs flanking the exon 18 and exon 19 549 
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(http://CRISPR.mit.edu) (Fig. 7). Transfection was carried out with Lipofectamine 2000 (ThermoFisher 550 
Scientific 11668019) reagent according to the manufacturer’s protocol. Knockout clones were confirmed 551 
by western blotting and by genotyping using primers spanning the deleted exons, and by reverse 552 
transcription followed by semi-quantitative PCR (RT-qPCR) with primers 553 
(AGGGAGCACAAGAGTACACCA and GGCATGCTGCCGAATTGCTA) within and downstream of  554 
the deleted exons, as shown in Fig. 7. Values were normalized to Sdha expression. Three to five 555 
independent knockout clones were analysed for each cell line. The expression of fourteen genes found to 556 
be differentially regulated between Het-U and Hom-P placenta, were then assessed by qPCR in p110α 557 
deficient TS and ES cells. 558 
 559 
Gene expression by qRT-PCR 560 
Total RNA was extracted from whole placental halves using the RNeasy Plus Mini Kit (Qiagen, UK) 561 
whereas total RNA was extracted from TS and ES cells using trizol (Invitrogen), chloroform and ethanol 562 
extraction. Multiscribe Reverse Transcriptase and random primers (Applied Biosystems) were used to 563 
synthesize cDNA from 2.5ug of RNA. Samples were analysed in duplicate by qRT-PCR (7500 Fast Real-564 
Time PCR System, Applied Biosystems, UK) using Sybr green chemistry and pairs of forward and 565 
reverse primers (Table S7). The expression of genes of interest were normalised to the expression of 566 
Gapdh or Sdha which was not affected by genotype. Data were analysed using the 2–ΔΔCT method for 567 
quantification. 568 
 569 
Western Blotting  570 
Protein expression was quantified using p110α antibody (1:500; Cell Signalling, 4249) as described 571 
previously (Sferruzzi-Perri et al., 2011). 572 
 573 
Statistics 574 
Data are presented as mean  SEM. Data were analysed using unpaired and paired t tests with Excel, as 575 
required or two-way ANOVA with GraphPad Prism 7. Data were considered statistically significant
 
when 576 
P<0.05. 577 
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Figure legends 821 
 822 
Fig. 1. Successful modulation of p110 expression in the conceptus. (A-B) Validation that Cyp19Cre 823 
(A) and Meox2Cre (B) are active in opposite compartments in the conceptus by crossing lines to the 824 
tdTomato reporter and assessing placentas and fetuses on day 16 of pregnancy.  Boxes in A and B are 825 
shown in high magnification in i and ii, respectively. Scale bar for fetuses and placentas in A and B = 826 
2mm and 1mm, in i and ii = 200m, and in iii and iv = 20m, respectively. (C) qRT-PCR for Pik3ca gene 827 
normalised to Gapdh in whole homogenates of fetus and placenta of Het-P, Het-F, Het-U and Hom-P 828 
mutants on day 19 of pregnancy, expressed as a ratio of their respective wild-type control (WT, denoted 829 
as a dotted line). Gapdh expression was not affected by genotype. *P < 0.05, **P < 0.01, and ***P < 830 
0.001 versus WT, unpaired t test. n≥4 per genotype. Het-F=heterozygous deficiency in the fetus, Het-831 
P=heterozygous deficiency in the placenta, Het-U=heterozygous deficiency in the fetus and placenta, 832 
Hom-P=heterozygous deficiency in the fetus and homozygous deficiency in the placenta, Jz=Junctional 833 
zone, Lz=Labyrinth zone, T=Trophoblast. 834 
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 836 
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 838 
 839 
 840 
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 842 
 843 
Fig. 2. Feto-placental growth is regulated by fetal but not trophoblast p110. (A)  Het-P (n=15) 844 
compared to WT (n=26) (B), Het-F (n=30) compared to WT (n=21) and (C) Het-U (n=18) compared to 845 
WT (n=26) on day 19 of pregnancy. *P < 0.05 and ***P < 0.001 versus WT, unpaired t test. Note, there 846 
was no significant difference in fetal weight between Het-F and WT when data were analyzed by paired t 847 
test. Data from individual conceptuses are shown and the mean is denoted as a horizontal line with SEM.  848 
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Fig. 3. Placental morphology is regulated by both fetal and trophoblast p110. (A) Het-P, (B) Het-F 857 
and (C) Het-U placental morphology on day 19 of pregnancy as determined by stereology. *P < 0.05, **P 858 
< 0.01, and ***P < 0.001 versus WT, unpaired t test. Data presented as means  SEM. Scale bar for 859 
hematoxylin and eosin-stained placental cross-sections is 500m. 6-10 placentas were assessed for each 860 
genotype for labyrinthine zone (Lz) volume and 4-5 analysed for Lz morphology.  861 
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Fig. 4. Placental nutrient transfer is adaptively increased in response to fetal and/or trophoblast 881 
loss of p110. (A-F) The capacity of the placenta to transport 3H-methyl-D glucose (MeG) and 14C-882 
amino isobutyric acid (MeAIB) relative to surface area available or to fetal weight (D-F) on day 19 of 883 
pregnancy for Het-P (n=15) (A, D), Het-F (n=24) (B, E) and Het-U (n=16) (C, F), expressed as a ratio of 884 
their respective WT control values (denoted as a dotted line, n=21, 18 and 21, respectively), *P < 0.05 885 
and ***P < 0.001 versus WT, unpaired t test. Data presented as means  SEM. 886 
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Fig. 5. Retaining trophoblast p110 is critical for the ability of the placenta to increase amino acid 931 
transport. MeG and MeAIB transport relative to surface area available (A) or to fetal weight (B) on day 932 
19 of pregnancy in Hom-P (n=16), expressed as a ratio of Het-U control values (denoted as a dotted line, 933 
n=16), *P < 0.05 versus Het-U, unpaired t test.  934 
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Fig. 6. Genes downstream of p110 in the trophoblast implicated in changes in placental phenotype 982 
on day 19 of pregnancy. (A) Top-scoring biological processes enriched in Hom-P (n=4) versus Het-U 983 
(n=5) placentas on day 19 determined by RNA-seq (see also Supplementary Table S5). GO terms 984 
enriched in up-regulated genes shown in green and those down-regulated in red. Three genes with the 985 
highest fold expression changes are indicated in parentheses. The line corresponds to P=0.05. (B) 986 
Representative photomicrographs of increasing magnification of cells in the placenta undergoing 987 
apoptosis in situ in Het-U and Hom-P mutants on day 19 of pregnancy. Arrows indicate cells undergoing 988 
cell death (Tunnel: TMR red, nuclei: DAPI). (C) Quantification of cells in the placenta undergoing 989 
apoptosis in situ for Het-U (n=8) versus Hom-P (n=8) on day 19 of pregnancy. Scale bar=200m, Tunnel: 990 
TMR red, nuclei: DAPI, Jz=Junctional zone, Lz=labyrinth zone. * P<0.05, unpaired t test. Data presented 991 
as means  SEM. (D) Transcription factors with binding sites enriched at the promoters of differentially 992 
expressed genes, as identified by Analysis of Motif Enrichment (AME). (E) Regulatory network built 993 
with the four TFs identified by AME analysis using ingenuity pathway analysis. In green are shown 994 
proteins that are down-regulated at mRNA level in Hom-P versus Het-P placentae, in blue are depicted 995 
TFs predicted as repressors and in orange TFs predicted as activators.  996 
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Fig. 7. PI3K p110α differentially affects the expression of genes in the trophoblast and fetal cell 1009 
lineages. (A) Details of CRISPR/Cas9 design to delete exons 18-19 of Pik3ca in trophoblast or 1010 
embryonic stem cells (TSC and ESC, respectively). The deletion in TSC (trophoblast stem cells) and ESC 1011 
(embryonic stem cells) was confirmed by (B) qRT-PCR analysis of exons 18-19 of Pik3ca and (C) by 1012 
Western blotting for p110α.  (D) The expression of candidate genes in Pi3kca wildtype (WT) and mutant 1013 
(Mut) TSC and ESC. Data in (D) are normalized against housekeeping Sdha. * P<0.05, **** P<0.0001, 1014 
two-ways ANOVA analysis followed by Fisher post hoc test.  Data presented as means  SEM. 1015 
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Fig.  8. Summary figure showing the phenotypes of all p110 mutants used in this study, which 1029 
together highlight that fetal and trophoblast p110α have distinct contributions in regulating 1030 
resource allocation to the growing fetus. Findings are from mice at day 19 of pregnancy, unless 1031 
indicated otherwise. AA=amino acid, BT=barrier thickness, FC=fetal capillaries, Lz=labyrinth zone, 1032 
MBS=maternal blood spaces, SA=surface area for exchange. 1033 
 1034 
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Table 1. Deleting the remaining p110 from fetal compartment of the conceptus results in fetal 1036 
lethality in Hom-F mutants between days 11 and 12 of pregnancy. Frequency of viable fetuses in a 1037 
litter per gestational age are displayed, with the number of litters in parentheses. 1038 
 1039 
 1040 
 1041 
 1042 
 1043 
 1044 
 1045 
 1046 
 1047 
 1048 
 1049 
Table 2. Deleting the remaining p110 from the trophoblast reduces fetal weight but does not alter 1050 
placental growth on day 19 of pregnancy, in Hom-P relative to Het-U controls. Conceptus weights 1051 
are from n≥18, Lz and Jz volume from n≥6 and Lz morphology from n≥4 per genotype.  Data are 1052 
presented as means  SEM. * versus Het-U, P<0.05, unpaired t test. 1053 
 1054 
 
Het-U Hom-P 
Fetus (mg) 1075±31 994±22* 
Placenta (mg) 84±3 89±3 
Labyrinthine zone (mm
3
) 38±3 36±2 
Junctional zone (mm
3
) 31±3 30±2 
Maternal blood spaces (mm
3
) 13±3 11±1 
Trophoblast (mm
3
) 20±1 22±2 
Fetal capillaries (mm
3
) 3±1 4±1 
Barrier thickness (m)  4.0±0.2 3.9±0.1 
Surface area (mm
2
) 11±1 10±1 
1055 
 WT Het-F Het-U Hom-F 
D10 (5) 23% 26% 34% 17% 
D11 (6) 35% 23% 29% 13% 
D12 (2) 50% 25% 25% 0% 
D13 (3) 39% 33% 28% 0% 
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Supplementary Materials: 1056 
 1057 
Fig.  S1. The expression of p110 protein by the mouse placenta on day 19 of pregnancy. 1058 
Representative stained section shown with negative control also displayed.  1059 
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Fig. S2. Junctional zone volume is not modified by fetal and/or trophoblast loss of p110. Placental 1082 
junctional zone volume on day 19 of pregnancy in Het-P (A), Het-F (B) and Het-U (C). n≥6 placentas 1083 
were assessed for each genotype. Data are presented as means  SEM. 1084 
 1085 
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Fig. S3. Total solute accumulation in response to fetal and/or trophoblast loss of p110. The 1091 
accumulation of 
3
H-methyl-D glucose (MeG) and 
14
C-amino isobutyric acid (MeAIB) on day 19 of 1092 
pregnancy for Het-P (n=15) (A, D), Het-F (n=24) (B, E) and Het-U (n=16) (C, F) with their respective 1093 
WT control values (n=21, 18 and 21, respectively), Data presented as means  SEM. 1094 
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Fig. S4. Total solute accumulation in Het-U versus Hom-P. MeG and MeAIB accumulation on day 19 1102 
of pregnancy in Het-U control values (n=16) and Hom-P (n=16). *P < 0.05 versus Het-U, unpaired t test 1103 
 1104 
 1105 
 1106 
1107 
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Fig.  S5. Sashimi plot showing RNA-seq reads for exons 18-20 of Pik3ca for the 4 Hom-P and 5 Het-1108 
U placentas analysed on day 19 of pregnancy. 1109 
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Fig.  S6. Validation of RNA-seq data. Validation performed by qRT-PCR for 16 genes in n=7 Het-U 1135 
and Hom-P placentas on day 19 of pregnancy. 1136 
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Fig. S7. Expression profiles of the genes identified as dysregulated in Hom-P versus Het-U 1159 
placentas in trophoblast stem cells (TS cells) and embryonic stem cells (ES cells), as determined by 1160 
analysis of existing RNA-seq datasets (Chrysanthou et al., 2018; Latos et al., 2015).  1161 
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 1181 
Table S1. Summary of the mouse strains and experimental crosses used in the study. * Note for 1182 
Cyp19Cre mutants (Het-P and Hom-P) the frequency is actually ~half than stated, due to mosaic activity 1183 
of this Cre line.  1184 
 1185 
Paternal 
genotype 
Maternal 
genotype 
Conceptus genotypes 
(for experiments) 
Frequency* Used for 
Meox2Cre (het) Pik3ca
Fl/Fl
 Pik3ca
Fl/+
 = WT 
Meox2Cre; Pik3ca
Fl/+
 = Het-F 
1:2 Day 19 collection 
for fetal weight and 
placental transport 
phenotype 
Pik3ca null 
(het); 
Meox2Cre (het) 
Pik3ca
Fl/Fl
 Pik3ca
Fl/+
 = WT 
Meox2Cre; Pik3ca
Fl/+
 = Het-F 
Pik3ca null het and Pik3ca
Fl/+
  
= Het-U 
Meox2Cre; Pik3ca
Fl/+
 and 
Pik3ca null het = Hom-F 
1:4 D10-13 collection 
for conceptus 
viability 
Pik3ca
Fl/Fl
 Pik3ca null (het); 
Cyp19Cre (het) 
Pik3ca
Fl/+
 = WT 
Cyp19Cre; Pik3ca
Fl/+
 = Het-P 
Pik3ca null het and Pik3ca
Fl/+
 
= Het-U 
Cyp19Cre; Pik3ca
Fl/+
 and 
Pik3ca null het = Hom-P 
1:4 Day 19 collection 
for conceptus 
viability, fetal 
weight and placental 
transport phenotype 
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Table S2. Deleting the remaining p110 from the trophoblast in Hom-P does not affect fetal 1203 
viability at day 19 of pregnancy. Frequency of viable fetuses in a litter are displayed, with data from 1204 
n=15 litters. Offspring genotypes were determined by conventional PCR, and in the case of Cyp19Cre 1205 
mutants, additionally by qRT-PCR to identify those with a sufficient level of Pik3ca deletion (frequency 1206 
is in parentheses). When the cut off for Pik3ca deletion in the placenta using qRT-PCR was applied 1207 
(<65% for Het-P and <30% for Hom-P), the frequency of Cyp19Cre mutants was ~50% less. 1208 
 1209 
 WT Het-P Het-U Hom-P 
Frequency by DNA genotyping (by qRT-PCR) 26% 23% (14%) 19% 32% (16%) 
 1210 
 1211 
 1212 
 1213 
Table S3. The effect of deleting the remaining p110 from the trophoblast in Hom-P on feto-1214 
placental growth relative to WT and Het-P. Hom-P * versus WT or † versus Het-P.  *P < 0.05 and 1215 
***P < 0.001, †P < 0.05 and †††P < 0.001, unpaired t test. Conceptus weights are from n≥15, Lz and Jz 1216 
volume from n≥6 and Lz morphology from n≥4 per genotype on day 19 of pregnancy. Data are presented 1217 
as means  SEM. 1218 
 1219 
 
WT Het-P Hom-P 
Fetus (mg) 1155±20 1152±25 994±22***††† 
Placenta (mg) 93±3 101±5 89±3† 
Labyrinthine zone (mm
3
) 47±2 46±4 36±2*** 
Junctional zone (mm
3
) 33±5 34±9 30±2 
Maternal blood spaces (mm
3
) 14±2 9±1 11±1† 
Trophoblast (mm
3
) 28±2 34±2 22±2††† 
Fetal capillaries (mm
3
) 5±1 3±1 4±1*† 
Barrier thickness (m)  
3.5±0.1 3.7±0.1 
3.9±0.1* 
Surface area (mm
2
) 
15±1 9±1 
10±1*** 
 1220 
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Table S4. The effect of deleting the remaining p110 from trophoblast in Hom-P on placental 1226 
transport capacity relative to WT and Het-P. Placental transport of 
3
H-methyl-D glucose (MeG) and 1227 
14
C-amino isobutyric acid (MeAIB) relative to surface area available or to fetal weight on day 19 of 1228 
pregnancy is shown as a ratio of WT values. Hom-P * versus WT or † versus Het-P. *P < 0.05, †P < 0.05 1229 
and †††P < 0.001, unpaired t test. Data are from n≥15 and presented as means  SEM. 1230 
 1231 
 
WT Het-P Hom-P 
MeG DPM /mm
2 
SA (ratio to WT) 1.0±0.1 1.8±0.1 1.4±0.1*† 
MeAIB DPM /mm
2 
SA (ratio to WT) 1.0±0.1 2.1±0.2 1.2±0.1††† 
MeG DPM/g fetus (ratio to WT) 1.0±0.1 1.1±0.1 1.1±0.1 
MeG DPM/g fetus (ratio to WT) 1.0±0.1 1.2±0.1 0.9±0.1 
 1232 
Table S5. List of differentially expressed genes obtained by RNA-seq comparing 5 Het-U and 4 Hom-1233 
P placentas on day 19 of pregnancy. 1234 
 1235 
EXCEL DOCUMENT 1236 
 1237 
Table S6. Functional predictions for the candidate genes enriched in TS and ES cells. 1238 
 1239 
EXCEL DOCUMENT 1240 
 1241 
 1242 
Table S7. Primer sequence for RT-qPCR, PCR screening and CRISPR gRNAs target 1243 
 1244 
RT-qPCR primers 
Gene Sequence 
Aldh1a3 F - ACTGGAGCTAGGAGGCAAGAAC  
R - GTAGACCTGCTCTTCCACGAAC 
Sult1e1  F - CTTCCAGGAGATGAAGAACAATCC 
R - GGAAGTGGTTCTTCCAGTCTCC 
Prl5a1 F - ACACTTCATCCCGCTCTGTC  
R - CAGAAGGTTTTTCCAGGCAGC 
Mgst1 F - GGTGAAAAGTCCCAGAAGTGC  
R - GCCATCAACACCTCATTGTCC 
Cdx2 F - GCTCTTTGCCAGGACTGACT 
R - CAGCCACCTTGGCTCAAGTA 
Pdlim3 F - TCATGCTGATGCACAGGACA 
R - GCGGTACCAATGGGTTTGAA 
Creb3l1 F - GTCCCCAGACACTTGGACTG 
R - GAACAGTGGTTGCGTTGGTC 
Cited2 F - ATCGGCTGTCCCTCTATGTG 
R - CCATTTCCAGTCCTTCCGTCT 
Selenbp1 F - GTGAGCAGTTTGCACACCAG  
R - GGCTTCTCCCATGTCCCTTT 
Nov F - AACAGGAATCGCCAGTGTGA 
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R - TTTCTTGGTGCGGAGACACT 
B2m F - TTCTGGTGCTTGTCTCACTGA 
R - CAGTATGTTCGGCTTCCCATTC 
Gzmc F - TGTGAGTCCCAGTTCCAAAGTT 
R - TGCTCTTTTACACACAAGCGG 
Gzmd F - TGTCTGTGGATATTAAGGGGAACA 
R - TGTCATTGAGCTTTGGACAGAG 
Gzme F - TGTCTCCTTTGCTCTCCTTCAA 
R - ATCCACAGACTTAACAAACGCC 
Gzmf F - ACATCCATCAATGCAACACAAAG 
R - TTGTTACACACGAGGGGTCC 
Gzmg F - TTTTAATAGAAAGCATGGCACCA 
R - GGCCTCACAGCTTTAGTTCTC 
Mpzl1 F - GGCTCCACGTGGTGGAAATA 
R - TGACTGGGCCCCGGTATAAT 
Mpzl2 F - TCTCCGTGGGTAAACTGTGC 
R - TAGGACAAAGGGCTGTGAGC 
Tmsb10 F - CGGAAGGCGCGGGAT 
R - TCAATGGTCTCTTTGGTCGGC 
Aqp5 F - ATCCATTGGCTTGTCGGTCA 
R - GTCCTACCCAGAAGACCCAGT 
Gapdh F - GGGAAATGAGAGAGGCCCAG 
R - GAACAGGGAGGAGCAGAGAG 
Sdha F - TGGTGAGAACAAGAAGGCATCA 
R - CGCCTACAACCACAGCATCA 
Pik3ca 
ex17-18 
F - GCTGCAGTTCAACAGCCACA 
R - GCAGGACCGAGTGAACAGGT 
Pik3ca 
ex19-20 
F - AGGGAGCACAAGAGTACACCA 
R - GGCATGCTGCCGAATTGCTA 
PCR screening primers  
Pik3ca 
F - ATCCCATGGAGAAAGAGACCAT 
R - GGTTACTTCTTTTGTAGGTTGCAC 
CRISPR gRNAs target sequences  
Pik3ca 
(exon 18-
19) 
Upstream exon 18 CACCGCGGAGTGGCTGCGGCCAAAC 
Upstream exon 18 CACCGTCAGCCGTATTTCCCCAGTT 
Downstream exon 19 CACCGTCTCTTCTGTCCGATGTCG 
Downstream exon 19 CACCGTGGTCACGCACACACGGTCT 
 1245 
 1246 
 1247 
 1248 
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